Trends & Forecasts

Today, the majority of the contract manufacturing market is made up of small molecules.

Mark Paxton was appointed CEO of Rx-360 in 2015. Here, he discusses the journey so far

Donald Trump has vowed to lower drug prices, but what about his policies in other areas?

Martin Van Trieste tells the emotional story behind the creation of Rx-360

Could manufacturers based in Russia be well placed to develop cheaper biopharmaceuticals?

What better way to engage with patients than partnering with Marvel Custom Solutions?

Elliott Berger offers his top 10 marketing tips for contract manufacturing organizations.

A campaign to counter criticism and a first foray into biosimilars… What’s new in business?

What does the legalization of medical cannabis mean for conventional pharmaceuticals?

PhRMA and the ABPI showcase the industry’s good side and the science behind the logo.